NASDAQ:APLM Stock Quote
7.0000
+0.8000 (12.90%)
Apollomics Inc. is a biotechnology company focused on the development of innovative cancer therapies
The company is dedicated to addressing unmet medical needs in oncology through the research and commercialization of novel drug candidates that target specific pathways associated with cancer growth and progression. By leveraging cutting-edge science and technology, Apollomics aims to create effective treatments that improve patient outcomes and quality of life for individuals battling various types of cancer. The company's strategic approach includes pursuing collaborations and partnerships to enhance its drug development pipeline.
